Shortages of chemotherapy are a growing challenge for the healthcare system. We present the burden of drug shortages of chemotherapeutics in the paediatric hemato-oncology unit of a tertiary care hospital and solutions that were used to manage them. Between January 2001 and December 2014, 54 individual shortages were detected, affecting a total number of 21 different drugs. In total, 4127 shortage days were registered with a mean duration of 196.5 SD ± 144.0 days per individual drug shortage. Methotrexate, doxorubicin and carboplatin had the longest supply disruptions. Solutions to address the problems were purchase of a generic alternative, a change of individual treatment plans, cohorting of patients and import from abroad.status: publish...
Drug shortage is a global issue affecting low, middle, and high-income countries. Many countries hav...
Drug shortage is a global issue affecting low, middle, and high-income countries. Many countries hav...
BACKGROUND: Shortages and unequal access to anticancer medicines for children and adolescents are a ...
Shortages of chemotherapy are a growing challenge for the healthcare system. We present the burden o...
Shortages of chemotherapy are a growing challenge for the healthcare system. We present the burden o...
This article describes the implications of shortages of pharmaceutical products used in conditioning...
Purpose: Drug shortages are a clear and growing challenge. Prominent shortages included oncology me...
BACKGROUND: Essential anticancer medicines are an indispensable component of multidisciplinary treat...
The platinum-based chemotherapy drugs cisplatin, carboplatin, and oxaliplatin remain, despite their ...
Over the past five years, the pharmaceutical supply chain has grown increasingly unreliable. Accordi...
Purpose: Cancer drug shortages have increased considerably over the past 5 years, but quantitative a...
<div><p>Drug shortages are a complex and global phenomenon. When a drug cannot be delivered at the m...
Drug shortages are a complex and global phenomenon. When a drug cannot be delivered at the moment of...
While most of the attention and spending in the oncology community in the United States has been foc...
[No abstract available]34112Kantarjian, H.M., Chemotherapy drug shortages: A preventable human disas...
Drug shortage is a global issue affecting low, middle, and high-income countries. Many countries hav...
Drug shortage is a global issue affecting low, middle, and high-income countries. Many countries hav...
BACKGROUND: Shortages and unequal access to anticancer medicines for children and adolescents are a ...
Shortages of chemotherapy are a growing challenge for the healthcare system. We present the burden o...
Shortages of chemotherapy are a growing challenge for the healthcare system. We present the burden o...
This article describes the implications of shortages of pharmaceutical products used in conditioning...
Purpose: Drug shortages are a clear and growing challenge. Prominent shortages included oncology me...
BACKGROUND: Essential anticancer medicines are an indispensable component of multidisciplinary treat...
The platinum-based chemotherapy drugs cisplatin, carboplatin, and oxaliplatin remain, despite their ...
Over the past five years, the pharmaceutical supply chain has grown increasingly unreliable. Accordi...
Purpose: Cancer drug shortages have increased considerably over the past 5 years, but quantitative a...
<div><p>Drug shortages are a complex and global phenomenon. When a drug cannot be delivered at the m...
Drug shortages are a complex and global phenomenon. When a drug cannot be delivered at the moment of...
While most of the attention and spending in the oncology community in the United States has been foc...
[No abstract available]34112Kantarjian, H.M., Chemotherapy drug shortages: A preventable human disas...
Drug shortage is a global issue affecting low, middle, and high-income countries. Many countries hav...
Drug shortage is a global issue affecting low, middle, and high-income countries. Many countries hav...
BACKGROUND: Shortages and unequal access to anticancer medicines for children and adolescents are a ...